TG Therapeutics Inc (STU:NKB2)
€ 41.2 -1.5 (-3.51%) Market Cap: 6.37 Bil Enterprise Value: 6.54 Bil PE Ratio: 18.07 PB Ratio: 12.55 GF Score: 78/100

TG Therapeutics Inc (STU:NKB2) Transcripts

  • 1